Stay updated on Pembrolizumab CNS Metastases Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab CNS Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab CNS Metastases Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page revision updated from v3.6.5 to v3.6.6, indicating an internal update to the page rendering or metadata. The change does not modify the study content or data presented on the page.
    Difference
    0.0%
    Check dated 2026-08-31T18:54:23.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, indicating a deployed update to the page. No visible changes to the study details or layout are reflected in the provided data.
    Difference
    0.0%
    Check dated 2026-08-10T13:24:27.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Investigator and affiliation details were updated: Nancy Wang, M.D., Massachusetts General Hospital, with credentials added, and Priscilla Brastianos, MD, removed from the record. This reflects a change in the study's listed leadership and contact information for NCT02886585.
    Difference
    0.5%
    Check dated 2026-07-27T05:54:36.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, indicating a minor platform update. It affects the site’s revision label but does not modify the study information shown on the page.
    Difference
    0.0%
    Check dated 2026-07-05T13:35:33.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    This update adds posted results and expands the description of primary and secondary outcomes, including intracranial and extracranial endpoints and toxicity measures, with definitions and time frames. It also adds study documents (protocol and informed consent) and notes the results submission/posting dates, reflecting new data availability and end-point details.
    Difference
    3%
    Check dated 2026-06-28T08:06:39.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    New user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) were added and the recruitment status updated to No longer looking for participants, clarifying how to engage with the study. A formatting adjustment to the Intervention/Treatment header accompanies a version update (Revision: v3.6.0) with the older revision tag removed.
    Difference
    0.4%
    Check dated 2026-06-13T16:53:27.000Z thumbnail image

Stay in the know with updates to Pembrolizumab CNS Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab CNS Metastases Clinical Trial page.